CDER Review Overhaul Will Include Input From Foreign Reviewers
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation & Research will invite input from foreign drug regulators as part of a planned revamping of its NDA review process, CDER Director Janet Woodcock, MD, indicated at a seminar for center staff Sept. 15.
You may also be interested in...
CDER Quality Assurance Unit To Conduct Workshops, Educational Sessions
The new Quality Assurance Unit in FDA's Center for Drug Evaluation & Research will be called upon to hold internal workshops and educational sessions to highlight well-conducted drug reviews and to update CDER medical officers on review "best practices."
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands